Current Topics in Medicinal Chemistry

Editor-in-Chief

Jia Zhou
Chemical Biology Program
Department of Pharmacology and Toxicology
University of Texas Medical Branch
Galveston, TX
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor

Perspectives in Medicinal Chemistry: Metallomics and New Targets in Metal-Based Drug Discovery

Volume:16   Issue: 29
Pp: 3381-3382
Diego La Mendola and Enrico Rizzarelli
DOI: 10.2174/156802661629161020215241
Published on: 19 October, 2016



Editorial: Current Approaches in the Treatment of Neuropsychiatric Diseases free to download

Volume:16   Issue: 29
Pp: 3383-3384
Peng Li
DOI: 10.2174/156802661629161020221913
Published on: 19 October, 2016



Dopamine Targeting Drugs for the Treatment of Schizophrenia: Past, Present and Future open access plus

Volume:16   Issue: 29
Pp: 3385-3403
Peng Li, Gretchen L. Snyder and Kimberly E. Vanover
DOI: 10.2174/1568026616666160608084834
Published on: 19 October, 2016




Inhibitors of Glycine Transporter-1: Potential Therapeutics for the Treatment of CNS Disorders

Volume:16   Issue: 29
Pp: 3404-3437
Christopher L. Cioffi and Peter R. Guzzo
DOI: 10.2174/1568026616666160405113340
Published on: 19 October, 2016




Orexin Receptor Antagonists: Historical Perspectives and Future Opportunities

Volume:16   Issue: 29
Pp: 3438-3469
Stephen P. Andrews, Sarah J. Aves, John A. Christopher and Rebecca Nonoo
DOI: 10.2174/1568026616666150929111607
Published on: 19 October, 2016




Recent Developments in Group I Metabotropic Glutamate Receptor Allosteric Modulators for the Treatment of Psychiatric and Neurological Disorders (2014-May 2015)

Volume:16   Issue: 29
Pp: 3470-3526
Guiying Li, Morten Jorgensen, Brian M. Campbell and Dario Doller
DOI: 10.2174/1568026616666160405113536
Published on: 19 October, 2016




Enhancing cAMP Levels as Strategy for the Treatment of Neuropsychiatric Disorders

Volume:16   Issue: 29
Pp: 3527-3535
Ana M. Garcia, Ana Martinez and Carmen Gil
DOI: 10.2174/1568026616666160426151306
Published on: 19 October, 2016




AMPA Receptor Positive Allosteric Modulators: Potential for the Treatment of Neuropsychiatric and Neurological Disorders

Volume:16   Issue: 29
Pp: 3536-3565
Tristan Reuillon, Simon E. Ward and Paul Beswick
DOI: 10.2174/1568026616666160627114507
Published on: 19 October, 2016